CoinVoice has recently learned that, according to PR Newswire, Nasdaq-listed company 180 Life Sciences (renamed to ETHZilla) announced that it currently holds 82,186 ETH, with an average acquisition price of $3,806.71, currently valued at $349 million. In addition to ETH, the company also holds approximately $238 million in cash equivalents. [Original link]